Genetic deletion as well as antibody-mediated inhibition of CD44 ameliorated obesity-related metabolic disorders in association with reduced WAT inflammation and hepatosteatosis despite the similar body weight in mice fed with HFD (28, 29). This evidence concerns the gene CD44 and obesity disorder.